Search

everythinglearnresearchcommunity

for

Search:↓

Higher RBP4 levels are linked to severe alopecia areata, but genetic variant rs3758539 doesn't affect baricitinib response.

Melanogenesis-related proteins may trigger immune responses in alopecia areata patients.

People with alopecia areata have higher levels of a heart disease marker in their blood.

Arg1+ macrophages may play a role in Alopecia Areata, offering new treatment targets.

A JAK1 variant causes hair loss, skin issues, and thyroid disease, but treatment with a specific inhibitor can help.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

People with alopecia areata have higher levels of a heart disease marker than those without hair loss.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

The girl's condition improved with treatment, showing no new autoimmune diseases and hair regrowth.

A man with hypoparathyroidism had other health issues that led to a diagnosis of a rare autoimmune disorder, APS-1.

A(1-7) treatment reduces symptoms of lupus in mice.

PPARα agonists may help treat alopecia areata by reducing inflammation.

Certain genetic variants may increase the risk of developing PCOS.

PON1 levels might indicate hair loss severity, but other health factors can affect this.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

Self-amplifying RNA could be a better option for protein replacement therapy with lower doses and lasting effects, but delivering it into cells is still challenging.

No effective treatment exists to stimulate hair growth in atrichia with papular lesions.

Higher levels of PD-L1 are linked to more severe hair loss in people with Alopecia Areata.

JAK1 inhibitor may effectively treat alopecia areata when TNF-α inhibitors and corticosteroids fail.

Abatacept may help some people with alopecia areata regrow hair.

Mutations in the hairless gene cause a rare form of permanent hair loss.

A Taiwanese patient had hair loss and skin bumps without the usual gene mutation, suggesting other genetic factors might be involved.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Higher CRHR1 levels in AA patients lead to increased inflammation.

Adalimumab may cause severe hair loss in some patients.

Lower adiponectin and higher leptin levels may predict hair loss in alopecia areata.

A certain gene variation is linked to a higher risk of polycystic ovarian syndrome in South Indian women.

Young men with early hair loss and high SAA3 levels are at higher risk for heart disease.

Blocking LFA-1 prevents hair loss in mice.

Genetic testing for hairless gene mutations is crucial to correctly diagnose and treat atrichia with papular lesions.